Scientists from MIT's Center for Cancer Research have developed a new mouse model that closely resembles Li-Fraumeni Syndrome (LFS) in humans, a syndrome that predisposes those affected to a broad range of cancers. Some 95 percent of LFS patients develop cancer by age 65. The work could not only lead to a treatment for LFS, but could also aid the development of treatments for other cancers.

Read more...